Assistant professor at Cedars-Sinai Medicine and medical director of the Hematology and Cellular Therapy Disease Research Group at the Cedars-Sinai Cancer Institute.
Approved Therapies Considered for Patients With Graft-Vs-Host Disease
Noah M. Merin, MD, PhD, discusses approved therapies in acute and chronic graft-vs-host disease.